Regenerex Pharma (RGPX) Debt Ratio (2017 - 2024)
Regenerex Pharma (RGPX) reported Debt Ratio of 0.24 for Q1 2024, down 98.81% year-over-year from 20.17 in Q2 2023, and up 7213.16% on a QoQ basis from 0.0 in Q4 2023.
Regenerex Pharma (RGPX) has 8 years of Debt Ratio data on file, last reported at 0.24 in Q1 2024.
- Quarterly Debt Ratio fell 98.81% year-over-year to 0.24 in Q1 2024, while the trailing twelve-month figure through Mar 2024 was 0.24 (down 98.81% YoY) and the FY2024 annual result came in at 0.24, down 98.81% from the prior year.
- Debt Ratio improved to 0.24 in Q1 2024 per RGPX's latest filing, from 0.0 in the prior quarter.
- Across five years, Debt Ratio topped out at 20.17 in Q1 2023 and bottomed at 0.0 in Q3 2023.
- The 5-year median for Debt Ratio is 8.59 (2022), against an average of 7.16.
- The widest annual swing landed in 2022, when Debt Ratio jumped 151525.55%; it then sank 99.98% in 2023.
- Tracing RGPX's Debt Ratio over 5 years: stood at 0.52 in 2020, then slumped by 98.3% to 0.01 in 2021, then jumped by 151525.55% to 13.28 in 2022, then tumbled by 99.98% to 0.0 in 2023, then jumped by 7213.16% to 0.24 in 2024.
- Per Business Quant, the three latest RGPX Debt Ratio figures stand at 0.24 (Q1 2024), 0.0 (Q4 2023), and 0.0 (Q3 2023).
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 0.24 |
| Dec 31, 2023 | 0.00 |
| Sep 30, 2023 | 0.00 |
| Mar 31, 2023 | 20.17 |
| Dec 31, 2022 | 13.28 |
| Sep 30, 2022 | 15.90 |
| Jun 30, 2022 | 12.52 |
| Mar 31, 2022 | 8.59 |
| Dec 31, 2021 | 0.01 |
| Sep 30, 2021 | 10.90 |
| Jun 30, 2021 | 11.81 |
| Mar 21, 2021 | 12.51 |
| Sep 30, 2020 | 0.52 |
| Jun 30, 2020 | 0.51 |
| Mar 31, 2020 | 0.51 |
| Dec 31, 2019 | 0.51 |
| Sep 30, 2019 | 0.52 |
| Jun 30, 2019 | 0.91 |
| Mar 31, 2019 | 1.24 |
| Dec 31, 2018 | 1.30 |
| Sep 30, 2018 | 0.04 |
| Jun 30, 2018 | 0.02 |
| Mar 31, 2018 | 4.45 |
| Dec 31, 2017 | 2.58 |
| Sep 30, 2017 | 2.05 |
| Jun 30, 2017 | 2.07 |